Drug	Gene	Type	Source
(4ar,6r,7r,7as)-6-[6-(benzylamino)-9h-purin-9-yl]tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide	EDN1	Text_Mining(decreases(expression))	CTD
(4ar,6r,7r,7as)-6-[6-(benzylamino)-9h-purin-9-yl]tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide	EDN1	Text_Mining(decreases(reaction))	CTD
(4ar,6r,7r,7as)-6-[6-(benzylamino)-9h-purin-9-yl]tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide	EDN1	Text_Mining(increases(expression))	CTD
(4ar,6r,7r,7as)-6-[6-(benzylamino)-9h-purin-9-yl]tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide	TGFB1	Text_Mining(decreases(reaction))	CTD
(4ar,6r,7r,7as)-6-[6-(benzylamino)-9h-purin-9-yl]tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide	TGFB1	Text_Mining(increases(expression))	CTD